Complementary therapies in clinical practice · 2026
Evaluation of the efficacy of laser acupuncture on uremic pruritus: A double-blind randomized clinical trial.
СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Juan Ying-Hsu, Ho Wen-Kuang, Tsai Jen-Pi, Tzeng Shinn-Jia, Liu Hsin-Ping, Lin Wei-Yong
Аннотация
BACKGROUND AND PURPOSE: Uremic pruritus is a common and distressing symptom among patients undergoing maintenance hemodialysis, impairing sleep and quality of life. Conventional treatments provide limited relief. This study evaluated the efficacy and safety of laser acupuncture as a complementary therapy for uremic pruritus.
MATERIALS AND METHODS: In this double-blind randomized controlled trial, sixty hemodialysis patients were randomly assigned in a 1:1 ratio to receive either laser acupuncture or sham laser treatment three times weekly for four weeks. Laser stimulation was applied at Quchi (LI11), Xuehai (SP10), and Baichongwo (EX-LE3). Primary outcomes were assessed using the 5-D itch scale and the Dermatology Life Quality Index (DLQI).
RESULTS: The laser acupuncture group showed statistically significant improvements in the 5-D itch scale score compared with the sham group (mean difference: -6.9; 95% confidence interval: -8.4 to -5.4; p < 0.001; effect size: 1.12). Significant improvement in DLQI scores was also observed in the laser acupuncture group (p < 0.001). No adverse events or treatment-related discomfort occurred during the trial.
CONCLUSION: Laser acupuncture alleviated pruritus severity and improved dermatology-related quality of life in hemodialysis patients, supporting its role as a safe complementary therapy for managing uremic pruritus.
MATERIALS AND METHODS: In this double-blind randomized controlled trial, sixty hemodialysis patients were randomly assigned in a 1:1 ratio to receive either laser acupuncture or sham laser treatment three times weekly for four weeks. Laser stimulation was applied at Quchi (LI11), Xuehai (SP10), and Baichongwo (EX-LE3). Primary outcomes were assessed using the 5-D itch scale and the Dermatology Life Quality Index (DLQI).
RESULTS: The laser acupuncture group showed statistically significant improvements in the 5-D itch scale score compared with the sham group (mean difference: -6.9; 95% confidence interval: -8.4 to -5.4; p < 0.001; effect size: 1.12). Significant improvement in DLQI scores was also observed in the laser acupuncture group (p < 0.001). No adverse events or treatment-related discomfort occurred during the trial.
CONCLUSION: Laser acupuncture alleviated pruritus severity and improved dermatology-related quality of life in hemodialysis patients, supporting its role as a safe complementary therapy for managing uremic pruritus.